As your orthopedic and wellness physician, my job is to help you understand both the promise and the caveats of GLP-1 therapy so you can make a fully informed decision about your musculoskeletal future
These services include areas such as nutrition coaching, dieticians, behavioral modification, exercise programs, and data collection and analytics to track it all
Our guide to why weight loss often fails outlines a realistic, layered approach
The pharmacy is provider-facing rather than consumer-facing
MJ Peptides continues building trust as a reliable source for premium research peptides and laboratory compounds designed strictly for scientific research applications

This is a pivotal moment for the food industry. Noting that 12% of the US population has tried the drugs, with 6% actively using them, Harold Schmitz at VC firm The March Group said the Ozempic era is helping to rejuvenate the foodtech space, which is now very much alive. Courtney McHugh, chief commercial officer at Amplifye, a UC Davis spinout with an enzyme that helps the body digest protein more effectively, added: Theres an entire secondary market that can come from any breakthrough technology. This is only the first generation of GLP-1 drugs and therefore the first generation of secondary markets, observed McHugh, who said GLP-1 drugs are driving interest in products that solve for energy levels, nutrient deficiencies, and gut issues. They are also prompting renewed interest in protein quality as well as quantity, she claimed